Danaher Corporation ( DHR) - Stock Earnings
DHR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 21, 2026 BeforeMarket | 2.11 / — | — | 6.6 billion / — | — |
DHR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.2 billion USD | 6.8 billion USD |
| 2026Q1 | 1.0 billion USD | 6.0 billion USD |
| 2026Q2 | 870.0 million USD | 6.3 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DHR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.7 billion USD | 23.9 billion USD |
| 2024 | 3.9 billion USD | 23.9 billion USD |
| 2025 | 3.6 billion USD | 24.6 billion USD |
| 2026 Est. | — | — |
DHR
List: Contenders
Price: $229.72
Dividend Yield: 0.66%
Forward Dividend Yield: 0.70%
Payout Ratio: 19.89%
Dividend Per Share: 1.60 USD
Earnings Per Share: 5.61 USD
P/E Ratio: 34.14
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.8 million
Ebitda: 1.3 billionMarket Capitalization: 153.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 34
DGR3: 14.19%
DGR5: 15.03%
DGR10: 30.00%
DGR20: 30.00%